Report Scope:
This report highlights the current and future market potential for human recombinant DNA and provides a detailed analysis of the competitive environment, regulatory scenario, drivers, restraints, opportunities, trends and key players in the market. The report also provides market projections from 2022 through 2027. An in-depth discussion of strategic alliances, industry structures, competitive dynamics, and market forces are also provided.
Report Includes:
- 24 data tables and 8 additional tables
- An overview of the global market for human recombinant DNA
- Estimation of the market size and analyses of global market trends, with data from 2020, 2021 with projections of compound annual growth rates (CAGRs) through 2026
- Highlights of the market potential for human recombinant DNA, based on product, application, and region
- Coverage of history and future of human recombinant DNA, and latest technological advancements of the industry
- Identification of market drivers, restraints and other forces impacting the global market and evaluation of current market size and forecast
- Coverage of regulatory landscape, product recalls, pipeline products, and discussion on future perspective, strategies, and developments of the industry
- Market share analysis of the key companies of the industry and coverage of events like mergers & acquisitions, joint ventures, collaborations or partnerships, and other key market strategies and a relevant patent analysis
- Company profiles of major players within the industry AbbVie Inc., Amgen Inc., Eli Lilly, Sanofi
Summary:
Recombinant DNA technology (RDT) is essential for improving health conditions, primarily by developing new vaccines and pharmaceuticals. The treatment strategies are improved by developing diagnostics kits, monitoring devices and new therapeutic approaches. Additionally, many other industries such as agriculture are benefiting from the research conducted on genetically modified organisms (GMO), for example microorganisms that are considered clean fuel producers and bio degraders.
Advances in oncology research for discovering underlying molecular mechanisms of cancerous cells to develop novel therapeutics is benefitting the market. The rising number of advanced cancer cases worldwide has significantly increased the need for developing DNA damage-response drugs. These drugs can improve cancer survival by providing a selective and well-tolerated treatment approach.
During the forecast period, the increasing cancer incidence is expected to drive growth in the global human recombinant DNA market. According to the REDACTED report of the World Cancer Research Fund International, breast cancer caused the second-highest number of new cancer cases (REDACTED) worldwide. According to GLOBOCAN, REDACTED% of new breast cancer cases in the Asia Pacific were registered in 2020.
Regulatory approvals that delay product marketing can adversely impact manufacturer revenues. Similarly, a delay in post-approval of a drug product for another therapeutic indication increases clinical trial costs and potentially affects the labeling and approval status of currently marketed products.
Human Recombinant DNA: Global Markets
Table of Contents
Chapter 1 Introduction
Introduction
Study Goals and Objectives
Reasons for Doing the Study
Intended Audience
Scope and Format
Methodology
Market Estimates
Information Sources
Geographical Breakdown
Analyst's Credentials
BCC Custom Research
Related BCC Research Reports
Chapter 2 Summary and Highlights
Chapter 3 Overview
Homologous Recombination (HR)
Targets for Cancer Therapy
Chapter 4 Impact of COVID-19 Pandemic
Chapter 5 Market Dynamics
Market Drivers
Increasing Incidences of Chronic Diseases
Growing Aging Population
Advancements in Manufacturing Technologies
Market Restraints
Price Controls
Entry of Biosimilars
Opportunities
Untapped Potential in Emerging Markets
Chapter 6 Market Breakdown by Product Type
Human Protein Replacements
Market Size and Forecast
Therapeutic Agents for Human Diseases
Market Size and Forecast
Vaccines
Types of Vaccines
Market Size and Forecast
Chapter 7 Market Breakdown by End User
Biotechnology and Pharmaceutical Industry
Market Size and Forecast
Research Laboratories and Academic Institutes
Market Size and Forecast
Chapter 8 Market Breakdown by Region
Global Market by Region
North America
Europe
Asia-Pacific
Rest of the World
Chapter 9 Competitive Landscape
Overview
Chapter 10 Company Profiles
ABBVIE INC.
ALEXION PHARMACEUTICALS
AMGEN INC.
ELI LILLY
MERCK & CO. INC.
SANOFI S.A.
TAKEDA PHARMACEUTICAL CO LTD.
List of Tables
Summary Table : Global Market for Human Recombinant DNA, by Region, Through 2027
Table 1 : Estimated World Population and Annual Growth, by Selected Age Group, Through 2030
Table 2 : Cancer Statistics Across Major Asian Countries, by Cancer Site/Type, 2020
Table 3 : Global Human Recombinant DNA Market, by Product Type, Through 2027
Table 4 : Global Market for Human Protein Replacements, by Region, Through 2027
Table 5 : Global Market for Therapeutic Agents for Human Diseases, by Region, Through 2027
Table 6 : Vaccine Types
Table 7 : Global Market for Vaccines, by Region, Through 2027
Table 8 : Global Market for Human Recombinant DNA, by End User, Through 2027
Table 9 : Global Market for Human Recombinant DNA in the Biotechnology and Pharmaceutical Industry, by Region, Through 2027
Table 10 : Global Market for Human Recombinant DNA in Research Laboratories and Academic Institutes, by Region, Through 2027
Table 11 : Global Market for Human Recombinant DNA, by Region, Through 2027
Table 12 : North American Market for Human Recombinant DNA, by Product Type Through 2027
Table 13 : North American Market for Human Recombinant DNA, by End User, Through 2027
Table 14 : North American Market for Human Recombinant DNA, by Country, Through 2027
Table 15 : European Market for Human Recombinant DNA, by Product Type, Through 2027
Table 16 : European Human Recombinant DNA Market, by End User, Through 2027
Table 17 : European Market for Human Recombinant DNA, by Country, Through 2027
Table 18 : Asia-Pacific Market for Human Recombinant DNA, by Product Type, Through 2027
Table 19 : Asia-Pacific Human Recombinant DNA Market, by End User, Through 2027
Table 20 : Asia-Pacific Market for Human Recombinant DNA, by Country, Through 2027
Table 21 : Japan: Total Number of New Cancer Cases in Both Genders, 2020
Table 22 : RoW Market for Human Recombinant DNA, by Product Type, Through 2027
Table 23 : RoW Market for Human Recombinant DNA, by End User, Through 2027
Table 24 : Leading Market Players in the Human Recombinant DNA Market Ecosystem
Table 25 : AbbVie Inc.: Business Segments
Table 26 : AbbVie Inc.: Financial Performance, Through 2020
Table 27 : Amgen: Financial Performance, Through 2020
Table 28 : Eli Lilly: Business Segments
Table 29 : Eli Lilly: Financial Performance, 2018-2020
Table 30 : Sanofi: Business Segments
Table 31 : Sanofi: Financial Performance, 2018-2020
List of Figures
Summary Figure A : Global Market for Human Recombinant DNA, by Region, 2020-2027
Summary Figure B : Global Market Shares of Human Recombinant DNA, by Region, 2021
Figure 1 : Global Market Shares of Human Recombinant DNA, by Product Type, 2021
Figure 2 : Global Market for Human Recombinant DNA, by Product Type, 2020-2027
Figure 3 : Global Market for Human Protein Replacements, 2020-2027
Figure 4 : Global Market for Therapeutic Agents for Human Diseases, 2020-2027
Figure 5 : Evolution of Vaccine Technologies
Figure 6 : Global Market for Vaccines, 2020-2027
Figure 7 : Global Market Shares of Human Recombinant DNA, by End User, 2021
Figure 8 : Global Market for Human Recombinant DNA, by End User, 2020-2027
Figure 9 : Global Market for Human Recombinant DNA in the Biotechnology and Pharmaceutical Industry, 2020-2027
Figure 10 : Global Market for Human Recombinant DNA in Research Laboratories and Academic Institutes, 2020-2027
Figure 11 : Global Market Shares of Human Recombinant DNA, by Region, 2021
Figure 12 : North American Market Shares of Human Recombinant DNA, by Product Type, 2021
Figure 13 : North American Market Shares of Human Recombinant DNA, by End User, 2021
Figure 14 : North American Market Shares of Human Recombinant DNA, by Country, 2021
Figure 15 : U.S. Market for Human Recombinant DNA, 2020-2027
Figure 16 : Canadian Market for Human Recombinant DNA, 2020-2027
Figure 17 : European Market Shares of Human Recombinant DNA, by Product Type, 2021
Figure 18 : European Human Recombinant DNA Market, Market Shares, by End User, 2021
Figure 19 : European Market Shares of Human Recombinant DNA, by Country, 2021
Figure 20 : Geriatric Population in Germany, 2000-2030
Figure 21 : German Market for Human Recombinant DNA, 2020-2027
Figure 22 : U.K. Market for Human Recombinant DNA, 2020-2027
Figure 23 : French Market for Human Recombinant DNA, 2020-2027
Figure 24 : Italian Market for Human Recombinant DNA, 2020-2027
Figure 25 : Spanish Market for Human Recombinant DNA, 2020-2027
Figure 26 : Rest of Europe Market for Human Recombinant DNA, 2020-2027
Figure 27 : Asia-Pacific Market Shares of Human Recombinant DNA, by Product Type, 2021
Figure 28 : Asia-Pacific Human Recombinant DNA Market, Market Shares, by End User, 2021
Figure 29 : Asia-Pacific Market Shares of Human Recombinant DNA, by Country, 2021
Figure 30 : New Cancer Cases in China, 2020
Figure 31 : Distribution of New Cancer Cases in China, 2020
Figure 32 : Chinese Market for Human Recombinant DNA, 2020-2027
Figure 33 : Japanese Market for Human Recombinant DNA, 2020-2027
Figure 34 : Indian Market for Human Recombinant DNA, 2020-2027
Figure 35 : Rest of Asia-Pacific Market for Human Recombinant DNA, 2020-2027
Figure 36 : New Cancer Cases in Africa, 2020
Figure 37 : RoW Market Shares of Human Recombinant DNA, by Product Type, 2021
Figure 38 : RoW Market Shares of Human Recombinant DNA, by End User, 2021
Figure 39 : AbbVie Inc.: Net Revenue, by Business Segment, 2020
Figure 40 : AbbVie Inc.: Net Revenue, by Region, 2020
Figure 41 : Amgen: Total Sales, by Product, 2020
Figure 42 : Amgen: Total Revenue, by Region, 2020
Figure 43 : Eli Lilly: Total Sales, by Product Segment, 2020
Figure 44 : Eli Lilly: Total Revenue, by Region, 2020
Figure 45 : Sanofi: Net Sales, by Business Segment, 2020
Figure 46 : Sanofi: Net Sales, by Region, 2020
Global Sanger Sequencing Service Market Growth (Status and Outlook) 2024-2030
Published: 04-Jan-2024 Price: US 3660 Onwards Pages: 149
According to our LPI (LP Information) latest study, the global Sanger Sequencing Service market size was valued at US$ 209 million in 2023. With growing demand in downstream market, the Sanger Sequencing Service is forecast to a readjusted size of US$ 206.7 million by 2030 with a CAGR of -0.2% during review period.
The research report highlights the growth potential of the global Sanger Sequencing Service market. Sanger Sequencing Service are expected to show stable growth in the future ......
Global Whole Exome Sequencing Market Growth (Status and Outlook) 2024-2030
Published: 04-Jan-2024 Price: US 3660 Onwards Pages: 110
According to our LPI (LP Information) latest study, the global Whole Exome Sequencing market size was valued at US$ 289.6 million in 2023. With growing demand in downstream market, the Whole Exome Sequencing is forecast to a readjusted size of US$ 633.2 million by 2030 with a CAGR of 11.8% during review period.
The research report highlights the growth potential of the global Whole Exome Sequencing market. Whole Exome Sequencing are expected to show stable growth in the future market. Ho......
Global Single Nucleotide Polymorphism (SNP) Genotyping Market Growth (Status and Outlook) 2024-2030
Published: 04-Jan-2024 Price: US 3660 Onwards Pages: 154
According to our LPI (LP Information) latest study, the global Single Nucleotide Polymorphism (SNP) Genotyping market size was valued at US$ 16530 million in 2023. With growing demand in downstream market, the Single Nucleotide Polymorphism (SNP) Genotyping is forecast to a readjusted size of US$ 66080 million by 2030 with a CAGR of 21.9% during review period.
The research report highlights the growth potential of the global Single Nucleotide Polymorphism (SNP) Genotyping market. Single ......
Global CRISPR and CRISPR-Associated (Cas) Genes Market Growth (Status and Outlook) 2024-2030
Published: 04-Jan-2024 Price: US 3660 Onwards Pages: 125
According to our LPI (LP Information) latest study, the global CRISPR and CRISPR-Associated (Cas) Genes market size was valued at US$ 1354.3 million in 2023. With growing demand in downstream market, the CRISPR and CRISPR-Associated (Cas) Genes is forecast to a readjusted size of US$ 10020 million by 2030 with a CAGR of 33.1% during review period.
The research report highlights the growth potential of the global CRISPR and CRISPR-Associated (Cas) Genes market. CRISPR and CRISPR-Associate......
Global Polymerase Chain Reaction (Pcr) Products Industry Research Report, In-depth Analysis of Current Status and Outlook of Key Countries 2023-2028
Published: 02-Jan-2024 Price: US 3380 Onwards Pages: 120
Market Overview of Global Polymerase Chain Reaction (Pcr) Products market:
According to our latest research, the global Polymerase Chain Reaction (Pcr) Products market looks promising in the next 5 years. As of 2022, the global Polymerase Chain Reaction (Pcr) Products market was estimated at USD XX million, and it's anticipated to reach USD XX million in 2028, with a CAGR of XX% during the forecast years.
This report covers a research time span from 2018 to 2028, and presents......
Next Generation Sequencing - Global Market Insights and Sales Trends 2024
Published: 27-Dec-2023 Price: US 3350 Onwards Pages: 102
This report provides market insight on the different segments, by players, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking By Company; 3) comprehensive presentation of the global market for Next Generation Sequencing, with both quanti......
Polymerase Chain Reaction (PCR) Products - Global Market Insights and Sales Trends 2024
Published: 27-Dec-2023 Price: US 3350 Onwards Pages: 124
This report provides market insight on the different segments, by players, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking By Company; 3) comprehensive presentation of the global market for Polymerase Chain Reaction (PCR) Products, wi......
Global Genotyping Market Status and Outlook 2023-2028
Published: 26-Dec-2023 Price: US 3160 Onwards Pages: 128
Genotyping is the technology that detects small genetic differences that can lead to major changes in phenotype, including both physical differences that make us unique and pathological changes underlying disease.
Our market research experts provide qualitative and quantitative analysis of the market based on involving economic and non-economic factors in the same report with market value (million USD) data for each segment and sub-segment. This way, clients can achieve all their goals wh......
Global Pyrosequencing Professional Survey Report 2023, Forecast to 2028
Published: 26-Dec-2023 Price: US 3280 Onwards Pages: 101
Pyrosequencing is a method of DNA sequencing that detects light emitted from nucleotide bases.
Our market research experts provide qualitative and quantitative analysis of the market based on involving economic and non-economic factors in the same report with market value (million USD) data for each segment and sub-segment. This way, clients can achieve all their goals while taking advantage of emerging opportunities. Technological advancements, new product launches, and market capital f......
SERVICES
Value for Money
We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
Ever Growing Inventory
Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
One Stop Solution
Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
Dedicated Client Engagement
Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
Saving Time and Efforts
Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
Payment Flexibility
Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
Post-Purchase Research Support
Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements.
Subscription Offers & Packages (Get in touch with us for more details -
[email protected] / +1 888 391 5441 )
- Ad Hoc
-
- Pay - as - you - go / Bucket Subscriptions
- Fixed Cost for #of reports
- Customize / Personalize as per your needs
